Thimerosal inactivated mycoplasma hyopneumoniae vaccine
US5338543A · kind A · utility
33Cited by
10References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 29, 1992 |
| Grant date | Aug 16, 1994 |
| Priority date | — |
| Expiry date | May 29, 2012 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S435/87
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to a method for making an inactivated vaccine of Mycoplasma hyopneumoniae by inactivating the bacteria with Thimerosal. The resulting bacterin is mixed with an adjuvant of aluminum hydroxide and DEAE dextran and injected into pigs. The resulting bacterin and adjuvant mixture can also be mixed with other bacteria such as Borderella and Pasteurella, for further adjuvant effect. Protective immunity against mycoplasmal pneumonia is elicited in swine using these vaccines.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.